NICE publishes new guideline on rare blood clotting associated with COVID-19 vaccination

Red blood cells

The new guideline aims to help healthcare professionals to identify and treat patients who develop vaccine-induced immune thrombocytopenia and thrombosis after receiving COVID-19 vaccination

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals